Biotech news continually updated from thousands of sources around the net.
Which Is the Only State That...
Should states lower the drinking age to 18?
Colossus Minerals Inc. . Miner. Down 8.5 cents, or 34 per cent, at 16.5 cents on 10.05 million shares.
Gilead Sciences Inc. says the U.S. government has approved its highly anticipated hepatitis C drug that is expected to offer a faster cure to millions of people infected with the liver-destroying virus.
Federal health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
Theravance and GlaxoSmithKline said today that their lung disease drug Breo Ellipta worked as a treatment for asthma in a clinical trial.
GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial.
Bausch + Lomb Inc.'s parent company said Thursday it had made further cuts to B+L's Rochester-area workforce.
Small stocks have brought big joy this year, but they've been so generous that some mutual fund managers question how much they have left to give.
Eli Lilly said Thursday its depression drug edivoxetine failed in late-stage clinical testing, and it doesn't plan to file for marketing approval of the drug.
New York Mayor Michael Bloomberg administration's is using its final days to cement its vision the city as an economic epicenter for the life sciences industry.
In this Thursday, Nov. 14, 2013, file photo, retired U.S. Air Force Master Sgt. Thomas Gipson, of Atlanta, right, has his resume looked over by Ralph Brown, a management and program analyst with the Centers for Disease Control and Prevention, during a job fair for veterans at the VFW Post 2681,Marietta, Ga.
Gilead Sciences Inc. Chairman and CEO John Martin netted nearly $19 million by selling 282,242 shares Monday at nearly 10 times the price at which he exercised options to buy the shares.
The Baltimore Development Corp. is offering a second round of job creation incentives to Rockville-based Emergent Biosolutions as the company prepares to expand its facility near Johns Hopkins Bayview Medical Center.
Pfizer has announced an update of its clinical trial data access policy that will simplify and broaden access to information gathered in Pfizer-sponsored clinical trials.
Medical instruments maker Harvard Bioscience said Wednesday that it will eliminate about 50 jobs, or 13 percent of its workforce, to save money and plans to reinvest some of the savings in expanding its business in China.
The report from Toronto-based Environmental Defence says the big five all have issues with chemicals that could be harmful to human health, but some are doing better than others.